Skip to main content

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

For the period ended Dec 27, 2025. Filed Feb 18, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 18, 2026

CRL$345.80-2.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Statements of Comprehensive Income (Loss) for fiscal yearsand

Fiscal Year
202520242023
Net income (loss)$(142,163)$25,291$480,370
Other comprehensive income (loss):
Foreign currency translation adjustment171,497(130,112)70,651
Pension and other post-retirement benefit plans (Note 14):
Prior service cost and (losses) gains arising during the period5,626(12,190)(5,376)
Amortization of net loss, settlement losses, and prior service benefit included in total cost for pension and other post-retirement benefit plans1,1861,596736
Unrealized gains (losses) on hedging instruments—(966)2,490
Other comprehensive income (loss), before income taxes178,309(141,672)68,501
Less: Income tax (benefit) expense related to items of other comprehensive income (loss) (Note 12)31,587(17,903)4,071
Comprehensive income (loss), net of income taxes4,559(98,478)544,800
Less: Comprehensive income related to noncontrolling interests, net of income taxes3,3352374,546
Comprehensive income (loss) attributable to common shareholders, net of income taxes$1,224$(98,715)$540,254
See Notes to Consolidated Financial Statements.
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.